• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC THERMOCOOL SMART TOUCH SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC THERMOCOOL SMART TOUCH SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Model Number D134805
Device Problems Signal Artifact/Noise (1036); Display or Visual Feedback Problem (1184); Device Sensing Problem (2917); Device-Device Incompatibility (2919); Patient Device Interaction Problem (4001)
Patient Problem Cardiac Tamponade (2226)
Event Date 01/15/2021
Event Type  Injury  
Manufacturer Narrative
The bwi product analysis lab received the device for evaluation.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Event Description
It was reported that a female patient (around (b)(6) year-old/around (b)(6) lbs) underwent a cardiac ablation procedure for persistent atrial fibrillation with a thermocool® smart touch® sf bi-directional navigation catheter and suffered cardiac tamponade requiring pericardiocentesis.Patient was under general anesthesia.At 9:45am the first transseptal puncture was performed with an abbot brk transseptal needle.The wire and stsf catheter were parked in the left atrial appendage (laa).The temperature of the stsf was displayed on the smartablate generator very sporadically.The ablation signals were not clear and there was a lot of noise seen from the intracardiac (ic) signals on the carto 3 system and the recording system.Defibrillator and anesthesia monitors were available to monitor patient¿s heart rhythm.A new stsf catheter was opened in the sterile field.Mapping was done to the left atrium (la) with a pentaray nav high-density mapping eco catheter.It was also reported that the distal electrode of the was blacked out on the carto 3 system.The cable was exchanged, and it appeared to be resolved but the electrode signal would flicker in and out.At 10:00am (before the stsf catheter could be exchanged with the one already was in the sterile field), the certified registered nurse anesthetists (crna) noticed, the patient became hypotensive and cardiac tamponade was confirmed by ultrasound.Pericardiocentesis was performed to drain about 600cc of fluid from the pericardial space.Reminder of the procedure was cancelled.The patient was reported in stable condition and was transferred to the cardiac intensive care unit for observation.Prolonged hospitalization was required.Physician¿s opinion regarding the cause of the adverse event is that it was procedure related.The catheter, which was not quite connected to the carto 3 system, was not visualized via the carto 3 system but it was seen on fluoro.The physician continued advancing the catheter, but he felt resistance as he was advancing it inside the heart.The physician felt this may have caused the effusion.Catheter irrigation was set at 2ml/min.Graph, vector and dashboard were used as force visualization features.Visitag was not used as no ablation was able to be performed.Force was use as coloring option.The resistance felt while advancing the stsf into the heart will not be coded as a product deficiency as it is most likely related to the inability to visualize the catheter through the carto 3 system which made it difficult to be introduced.Since this event is life threatening and required intervention to prevent permanent impairment of a body function or permanent damage to a body structure, it is to be considered serious and mdr-reportable.
 
Manufacturer Narrative
On 2/23/2021, the product investigation was completed.It was reported that a female patient (around 67 to 75 year-old/around 150 lbs) underwent a cardiac ablation procedure for persistent atrial fibrillation with a thermocool® smart touch® sf bi-directional navigation catheter and suffered cardiac tamponade requiring pericardiocentesis.Patient was under general anesthesia.At 9:45am the first transseptal puncture was performed with an abbot brk transseptal needle.The wire and stsf catheter were parked in the left atrial appendage (laa).The temperature of the stsf was displayed on the smartablate generator very sporadically.The ablation signals were not clear and there was a lot of noise seen from the intracardiac (ic) signals on the carto 3 system and the recording system.Defibrillator and anesthesia monitors were available to monitor patient¿s heart rhythm.A new stsf catheter was opened in the sterile field.Mapping was done to the left atrium (la) with a pentaray nav high-density mapping eco catheter.It was also reported that the distal electrode of the was blacked out on the carto 3 system.The cable was exchanged, and it appeared to be resolved but the electrode signal would flicker in and out.At 10:00am (before the stsf catheter could be exchanged with the one already was in the sterile field), the certified registered nurse anesthetists (crna) noticed, the patient became hypotensive and cardiac tamponade was confirmed by ultrasound.Pericardiocentesis was performed to drain about 600cc of fluid from the pericardial space.Reminder of the procedure was cancelled.The patient was reported in stable condition and was transferred to the cardiac intensive care unit for observation.Prolonged hospitalization was required.Device evaluation details: the device was visually inspected and it was found in good normal conditions.Per the complaint, several test were performed.A deflection test was performed and the catheter was found within specifications.Also, sensor functionality was tested on carto 3 system and no anomalies were observed.Then, stockert generator compatibility was tested and no temperature nor impedance issues were detected.Next to it, an electrical test was performed and no electrical malfunction was observed.Next, catheter irrigation was tested and no irrigation issues were detected.Finally an od test was performed and the catheter diameters were found within specifications.A manufacturing record evaluation was performed for the finished device 30452544m number, and no internal actions related to the reported complaint condition were identified.The customer complaint regarding the adverse event cannot be duplicated as intended.The instructions for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation or tamponade.The device is working in specification.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL SMART TOUCH SF BI-DIRECTIONAL NAVIGATION CATHETER
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
33 technology drive
irvine CA 92618
MDR Report Key11314283
MDR Text Key238692903
Report Number2029046-2021-00150
Device Sequence Number1
Product Code LPB
UDI-Device Identifier10846835010183
UDI-Public10846835010183
Combination Product (y/n)N
PMA/PMN Number
P030031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 01/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/11/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/10/2021
Device Model NumberD134805
Device Catalogue NumberD134805
Device Lot Number30452544M
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/01/2021
Date Manufacturer Received02/23/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ABBOT BRK TRANSSEPTAL NEEDLE; CARTO 3 SYSTEM; PENTARAY NAV ECO; SMARTABLATE GENERATOR; THERMOCOOL SMARTTOUCH; UNSPECIFIED RECORDING SYSTEM
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
-
-